To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

777.40a day ago
777.40a day ago
arrow

LOWER/UPPER CIRCUITS

703.40
777.40
arrow
Orchid Pharma Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 11.66%, in the last year to ₹949.4 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 8.13% in the last year to ₹99.66 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 39.56, lower than its sector PE ratio of 43.86.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 148.62%
Net profit growth 5Y CAGR : %
Orchid Pharma Ltd Top mutual funds holding
arrow
Orchid Pharma (Orchid) established as an export-oriented unit (EOU) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research manufacturing and marketing. The company enjoy a multi-therapeutic presence across segments like anti-infectives anti-inflammatory central nervous system (CNS) cardio vascular segment (CVS) nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (API) finished dosage forms. The company has globally present through alliances and partnerships with globally reputed majors.
personal

Grow your wealth with more research recommendations

+91